Did generic drug makers act as a 'private sector cartel?'
Clip: 05/15/2019 | 5m 44s
Affordable health care is a persistent concern for Americans and a topic of great political debate. Typically, generic prescription drugs offer a cheaper alternative to name brands, but a new multi-state lawsuit alleges that their manufacturers have been artificially raising prices. John Yang talks to William Tong, attorney general of Connecticut, whose office has been leading the investigation.
Aired: 05/15/19Video has closed captioning.
Problems Playing Video?
Major corporate funding for the PBS NewsHour is provided by BNSF, Consumer Cellular, Leidos, Babbel, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Mutual of America. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.